NHSCT Diabetes Research Team – Recruit to Boehringer Ingelheim Trial: SYNCHRONIZE™ CVOT

April 12, 2024

Our Diabetes research team based at Antrim Area Hospital are on a recruitment roll. The team includes Ms Moyra McMaster and Ms Natalie Hanley led by NI’s only Primary Investigator  Dr Anna Strzelecka. They have recruited 3 patients within a month of opening. This is no easy task and shows the hard work and dedication of the NHSCT based research team.


SYNCHRONIZE™ CVOT  is a Phase 3, randomised, double-blind, parallel-group, event driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight related complications or risk factors for CVD.


The study is led by the University Hospitals of Leicester NHS Trust and Chief Investigator Dr Manish Saxena.


To find out more about SYNCRONIZE click here.